Zacks Investment Research on MSN
FDA expands IONS' Tryngolza label to treat severe hypertriglyceridemia
Ionis Pharmaceuticals IONS announced that the FDA has approved its wholly owned drug, Tryngolza (olezarsen), for a new ...
On Wednesday, the U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s PFE Ibrance (palbociclib) regimen for ...
After 35 years engaged in the research and development of pharmaceutical products, Ionis began marketing its drugs for the ...
Since then, a large study known as the TRAVERSE trial followed more than 5,200 men and found no meaningful rise in major ...
Merck (MRK) stock is in focus as the FDA approves a label expansion for the company's kidney cancer drug Welireg with its ...
The FDA has updated the safety labeling for the over-the-counter weight loss aid alli (orlistat) to include warnings about acute kidney injury.
HHS Secretary Robert F Kennedy Jr says FDA’s ultra-processed food definition is nearing release and could drive major changes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results